Posaconazole Treatment of Invasive Fungal Infection (IFI) (P05551)
Status:
Completed
Trial end date:
2010-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this multicenter, open label study, is to evaluate the safety and efficacy of
a 12-week treatment with Posaconazole Oral Suspension in participants with IFI